CellHit:一个网络服务器来预测和分析癌症患者的药物反应能力
Francesco Carli1,2, Natalia De Oliveira Rosa1, Simon Blotas1
1Laboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Piazza dei Cavalieri 7, 56126 Pisa, Italy.
Nucleic acids research
|May 16, 2025
概括
CellHit是一个新的网络服务器,可以从患者的转录基因数据中预测癌症药物反应. 它使用先进的计算方法和大型数据集来提供可解释的结果,帮助精确瘤学研究.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 从转录组数据预测癌症药物敏感性对于精确瘤学至关重要.
- 现有的方法往往缺乏患者和细胞系数据之间的稳健对齐.
- 研究界需要可访问的工具来分析药物反应.
研究的目的:
- 介绍CellHit网络服务器,用于使用转录组数据预测和分析癌症药物反应.
- 为没有编程专业知识的研究人员提供一个直观的,基于Web的平台.
- 通过使先进的药物敏感性预测可访问,使精确瘤学民主化.
主要方法:
- 药物基因组学数据集 (GDSC,PRISM) 和转录组数据 (CCLE,TCGA) 的整合.
- 一个涉及预处理,基因归算和使用批次校正,增强的Celligner和参数UMAP进行强有力的对齐的计算管道.
- 部署预先训练的最先进的模型来预测药物敏感性.
主要成果:
- 塞尔希特服务器提供了一个直观的界面,具有交互式可视化,包括低维嵌入和药物敏感性热图.
- 结果包括上下文元数据,基于SHAP的特征重要性,以及用于增强解释的转录组邻居.
- 可用于TCGA样本的预计算预测和用户输入样本的定制分析功能.
结论:
- CellHit提供了一个强大且易于使用的平台,用于从转录组数据中预测癌症药物敏感性.
- 该工具通过先进的可视化和特征重要性分析简化了解释和假设生成.
- 通过为更广泛的科学界提供快速,可解释的药物反应预测,CellHit使精确瘤学研究民主化.
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:21Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K